The NCCN Guidelines for Head and Neck (H&N) Cancers provide treatment recommendations for cancers of the lip, oral cavity, pharynx, larynx, ethmoid and maxillary sinuses, and salivary glands. JNCCN Journal of the National Comprehensive Cancer Network, 16(5), 479-490. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Head and Neck Cancers provide treatment recommendations for cancers of the lip, oral cavity, pharynx, larynx, ethmoid and maxillary sinuses, and salivary glands. National Comprehensive Cancer Network guidelines recommend patients with head and neck cancer (HNC) receive treatment at centers with expertise, but whether provider experience affects survival is Recently, the National Comprehensive Cancer Network (NCCN) Guidelines for Head and Neck Cancers expanded to include proton beam therapy (PBT) as an appropriate treatment option in specific cases - particularly tumors in and around the obit of the eye and base of the skull. The authors of a PLOS One research article proposed that the dramatic rise in the incidence of thyroid cancer in the United States is "largely due to overdiagnosis, the diagnosis of tumors that would have never manifest clinically if untreated." And overdiagnosis, they asserted, "may relate to defensive medicine"—in other words Multidisciplinary Head and Neck Symposium; Head and Neck Cancer Survivorship Care. February 27, 2017. Learn more about how advocates help create guidelines on the Cancer.Net Blog. Annually, ASCO will review guideline topic proposals from ASCO members. The NCCN Head and Neck Cancers guidelines address tumors arising in the lip, oral cavity, oropharynx, hypopharynx, glottic and supraglottic larynx, paranasal (ethmoid and maxillary) sinuses, nasopharynx, and salivary glands, as well as occult primary cancer. These NCCN Guidelines Insights focus on recent updates to the 2015 NCCN Guidelines for Head and Neck (H&N) Cancers. These Insights describe the different types